idarubicin has been researched along with Bone Marrow Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, F; Kaplan, S; Martini, A; Togni, P; Varini, M | 1 |
| Mehta, J; Philpott, N; Powles, R; Treleaven, J | 1 |
| Tamura, K | 1 |
| Albitar, M; Anderlini, P; Andersson, B; Beran, M; Champlin, R; Claxton, D; Estey, E; Gajewski, J; Giralt, S; Kantarjian, H; Keating, M; Khouri, I; Koller, C; Kornblau, S; Kørbling, M; Mehra, R; O'Brien, S; Przepiorka, D; Rondón, G; van Besien, K | 1 |
| Bozzi, D; Brandi, M; Calabrese, P; De Lena, M; Romito, S | 1 |
| Cox, G; Gillies, H; Harper, P; Johnson, S; Liang, R; Parapia, L; Rogers, H | 1 |
1 review(s) available for idarubicin and Bone Marrow Diseases
| Article | Year |
|---|---|
A phase I study of idarubicin hydrochloride in patients with acute leukemia. The Idarubicin Study Group of Japan.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Area Under Curve; Bone Marrow Diseases; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Idarubicin; Japan; Leukemia; Male; Middle Aged; Molecular Structure | 1996 |
3 trial(s) available for idarubicin and Bone Marrow Diseases
| Article | Year |
|---|---|
Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Diseases; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Etoposide; Female; Gastrointestinal Diseases; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prospective Studies; Radiotherapy; Remission Induction; Salvage Therapy; Treatment Outcome | 1994 |
A phase I study of idarubicin hydrochloride in patients with acute leukemia. The Idarubicin Study Group of Japan.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Area Under Curve; Bone Marrow Diseases; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Idarubicin; Japan; Leukemia; Male; Middle Aged; Molecular Structure | 1996 |
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cladribine; Combined Modality Therapy; Cytarabine; Feasibility Studies; Female; Filgrastim; Graft vs Host Reaction; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Recombinant Proteins; Remission Induction; Salvage Therapy; Treatment Outcome; Vidarabine | 1997 |
3 other study(ies) available for idarubicin and Bone Marrow Diseases
| Article | Year |
|---|---|
Phase I trial of 4-demethoxydaunorubicin with single i.v. doses.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Diseases; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Kinetics; Male; Middle Aged; Neoplasms | 1982 |
4-Demethoxydaunorubicin administered orally in advanced breast cancer. A phase II study.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Aged; Bone Marrow Diseases; Bone Neoplasms; Breast Neoplasms; Daunorubicin; Female; Humans; Idarubicin; Middle Aged; Nausea; Soft Tissue Neoplasms; Stomach Ulcer; Vomiting | 1988 |
Phase II trial of idarubicin in patients with advanced lymphoma.
Topics: Antibiotics, Antineoplastic; Bone Marrow Diseases; Daunorubicin; Drug Evaluation; Heart Diseases; Humans; Idarubicin; Lymphoma | 1988 |